Abstract
In vitro ribosome construction could enable studies of ribosome assembly and function, provide a route toward constructing minimal cells for synthetic biology, and permit the construction of ribosome variants with new functions. Toward these long-term goals, we recently reported on an integrated, one-pot ribosomal RNA synthesis (rRNA), ribosome assembly, and translation technology (termed iSAT) for the construction of Escherichia coli ribosomes in crude ribosome-free S150 extracts. Here, we aimed to improve the activity of iSAT through transcriptional tuning. Specifically, we increased transcriptional efficiency through 3′ modifications to the rRNA gene sequences, optimized plasmid and polymerase concentrations, and demonstrated the use of a T7-promoted rRNA operon for stoichiometrically balanced rRNA synthesis and native rRNA processing. Our modifications produced a 45-fold improvement in iSAT protein synthesis activity, enabling synthesis of 429 ± 15 nmol/l green fluorescent protein in 6 h batch reactions. Further, we show that the translational activity of ribosomes purified from iSAT reactions is about 20% the activity of native ribosomes purified directly from E. coli cells. Looking forward, we believe iSAT will enable unique studies to unravel the systems biology of ribosome biogenesis and open the way to new methods for making and studying ribosomal variants.
INTRODUCTION
Escherichia coli 70S ribosomes are complex macromolecular machines consisting of three ribosomal RNA (rRNA) molecules and 54 ribosomal proteins (r-proteins). The large subunit, 50S, consists of 23S and 5S rRNA and 33 r-proteins, while the small subunit, 30S, consists of 16S rRNA and 21 r-proteins. 70S ribosomes are capable of sequence-defined polymerization of amino acid monomers into proteins.
Over the last several decades, in vitro reconstitution of ribosomes from purified native rRNA and r-proteins have played a transformative role in dissecting molecular mechanisms that define ribosome assembly, including r-protein maps (1–6). However, assembly of E. coli ribosomes from in vitro transcribed rRNA using classical reconstitution methods remains inefficient, especially for the 50S subunit. Assembly of 50S subunits using in vitro transcribed 23S rRNA have led to only ‘marginally functional’ particles (7). Inefficiencies arise because in vitro transcribed 23S rRNA lacks the appropriate post-transcriptional modifications, as elegantly shown by Green and Noller (8). Even in vivo 50S assembly can be disrupted by a lack of post-transcriptional methylation of 23S rRNA (9). It is further hypothesized that the separation of 23S rRNA transcription and ribosome assembly used in classical 50S reconstitution experiments may also reduce assembly efficiency (10,11).
Despite inefficiencies of classical reconstitution methods, in vitro construction of E. coli ribosomes is a topic of rapidly growing interest. The driving force behind this growth is 3-fold. First, new approaches in cytoplasmic mimicry in vitro have enabled more active and efficient ribosome assembly and cell-free protein synthesis (CFPS) systems (11–13). Second, there is resurgence in efforts to build minimal cells from defined components (14–18). Third, the lack of cellular viability constraints opens the aperture to study rRNA variants with deleterious miscoding phenotypes or altered functions that would not be identified in classical genetic screens (7). For example, in vitro systems should make possible the study of the protein synthesis machinery under a variety of non-physiological conditions, such as altered pH, temperature and redox level (8,19–25). Additionally, in vitro systems have greater potential than in vivo systems to explore ribosomal variants (7). Specialized orthogonal ribosomes, which utilize 16S rRNA with a modified anti-Shine Dalgarno sequence, offer an alternative approach to create and study independent pools of 30S subunits in vivo (26). However, this technique is limited to 30S subunits because 50S subunits freely exchange between pools of native and orthogonal 30S subunits (27). Further, leaky translation of mRNAs by orthogonal ribosomes can lead to dominant growth defects that also limit this approach (26). In vitro ribosome construction could overcome these limitations and allow for manipulation of both ribosomal subunits.
Recently, our lab developed an integrated synthesis, assembly and translation (iSAT) technology for E. coli 70S ribosome biogenesis in vitro (11). iSAT combines in vitro rRNA transcription, ribosome assembly of the rRNA with purified total protein of 70S ribosomes (TP70), and translation of a reporter protein as a measure of ribosome activity (Figure 1) (11). This contrasts with previous approaches of in vitro ribosome reconstitution because rRNA transcription and ribosome assembly are co-activated in one reaction as it occurs in vivo (8,22–23,25). Further, ribosome assembly and functional activity (i.e. translation) are linked. The key to this methodology lies in the recreation of near-physiological salt conditions to allow these biological processes to occur at 37°C without magnesium or temperature shifts previously required for ribosome reconstitution from purified components (11,22–23,28).
Unfortunately, iSAT remains inefficient. 70S iSAT ribosomes using in vitro transcribed rRNA showed 12% luciferase synthesis activity compared to ribosomes assembled in the same system from purified total rRNA of 70S ribosomes (TR70) and TP70 (11). For comparison, in conventional reconstitution systems, 50S subunits assembled from in vitro transcribed E. coli 23S rRNA have about 0.02% activity compared to 50S subunits assembled from purified native 23S rRNA as measured by the fragment reaction, and the addition of the osmolytes telithromycin and trimethylamine-oxide only increases activity to 3% (25). As a result of these inefficiencies, our development of the iSAT system originally focused on individual subunit assembly, as opposed to simultaneous assembly of both subunits, in order to improve reporter signal strength and identify differences between 30S and 50S subunit assembly.
Here we hypothesized that iSAT activity could be increased by transcriptional tuning to improve rRNA transcription and processing efficiency. First, we introduced 3′ gene modifications to existing rRNA-encoding plasmids. Previously, the plasmids encoding 16S and 23S rRNA lacked transcriptional termination and likely 3′ end processing, resulting in rRNA of variable length. We tested modifications including plasmid linearization, transcriptional termination and ribozyme cleavage (Figure 1). Second, we manipulated plasmid and polymerase concentrations. With co-transcription of three plasmids encoding 16S and 23S rRNA and a reporter protein mRNA, all utilizing the T7 RNA polymerase (RNAP), we hypothesized that improving transcriptional balance would be critical to improving iSAT activity. Third, in an attempt to better mimic in vivo ribosome biogenesis, we used a native rRNA operon in the iSAT system to achieve stoichiometrically balanced synthesis of all three rRNA molecules and to utilize native RNase processing. For the operon-based iSAT system, concentrations of transcriptional components were optimized as with the original separate plasmid iSAT system. Throughout this research, changes to the iSAT system were assessed via measurement of reporter protein synthesis and visualization of rRNA by gel electrophoresis. The efforts reported here achieved a 45-fold overall improvement in iSAT protein synthesis activity, and demonstrated that RNA processing enzymes are present and active in the S150 extract. We anticipate that this newfound understanding and technical advance will lead to new efforts in studying and manipulating ribosome biogenesis.
MATERIALS AND METHODS
70S. Ribosome purification
For native E. coli 70S ribosome purification, MRE600 E. coli cells were grown to 3.0 OD600 in a 10 l fermentor (Sartorius), pelleted, and flash-frozen. Cell pellets were resuspended in Buffer A (20 mM Tris-HCl (pH 7.2 at 4°C), 100 mM NH4Cl, 10 mM MgCl2, 0.5 mM EDTA, 2 mM DTT) at a ratio of 5 ml of buffer per 1 g of cells. 200 μl Halt Protease Inhibitor Cocktail (Thermo Fisher Scientific Inc.) and 75 μl RNase Inhibitor (Qiagen) were added for every 4 g of cells in the suspension. The cells were lysed at approximately 20 000 psi with an EmulsiFlex-C3 homogenizer (Avestin). An equivalent dose of RNase Inhibitor and 3 μl 1 M DTT per milliliter were added to the lysate prior to two clarification spins at 30 000 g and 4°C for 30 min. Supernatant equivalent to S30 crude extract was recovered and gently layered into Ti45 ultracentrifuge tubes on top of an equivalent volume of a sucrose cushion, Buffer B (20 mM Tris-HCl (pH 7.2 at 4°C), 100 mM NH4Cl, 10 mM MgCl2, 0.5 mM EDTA, 2 mM DTT, 37.7% sucrose). Samples were then centrifuged at 90 000 g (33 900 rpm in Ti45 rotor) and 4°C for 20 h. Supernatant was recovered for S150 extract (see below), and the remaining clear ribosome pellet was gently washed and resuspended in Buffer C (10 mM Tris-OAc (pH 7.5 at 4°C), 60 mM NH4Cl, 7.5 mM Mg(OAc)2, 0.5 mM EDTA, 2 mM DTT). Concentration of resuspended ribosomes was determined from A260 NanoDrop readings (1 A260 unit of 70S = 24 pmol 70S (29)). Ribosomes were then aliquoted and flash-frozen for use as purified 70S ribosomes and for purification of native rRNA and r-proteins.
S150 extract preparation
Supernatants collected from the 70S ribosome pellets were spun at 150 000 g and 4°C for an additional 3 h. The top two-thirds of the supernatant was recovered and dialyzed in reconstituted Spectra/Por® 3 dialysis membrane tubing (3500 Da MWCO) against a high salt S150 extract buffer (10 mM Tris-OAc (pH 7.5 at 4°C), 10 mM Mg(OAc)2, 20 mM NH4OAc, 30 mM KOAc, 200 mM KGlu, 1 mM spermidine, 1 mM putrescine, 1 mM DTT). Dialysis buffer volume was 50-fold greater than sample volume and exchanged after 2 h for three dialysis steps. A fourth dialysis was performed overnight for 15 h. Extract was clarified at 4000 g for 10 min and concentrated 6- to 8-fold in 3000 Da MWCO Centriprep concentrators (EMD Millipore) to account for dilution during preparation. Final protein concentration of S150 extract was 4.6 ± 0.5 mg/ml, as determined by a Bradford assay using bovine serum albumin as a standard. S150 extract samples were then aliquoted, flash-frozen and stored at −80°C.
Total protein of 70S ribosomes (TP70) preparation
Purified E. coli 70S ribosomes were diluted 5-fold in Buffer C and passed through a second sucrose cushion by ultracentrifugation as in the initial ribosome purification. The resulting pellet was again resuspended in Buffer C and the polyamines spermine and spermidine were added to final concentrations of 0.2 mM and 2 mM, respectively. One-tenth of the sample volume of 1 M Mg(OAc)2 was added, and two volumes of glacial acetic acid were added to precipitate rRNA. This sample was vortexed at 4°C for 45 min and then centrifuged at 16 000 g for 30 min to pellet precipitated rRNA. Supernatant containing r-proteins was collected and mixed with 5 volumes of chilled acetone and stored overnight at −20°C. Precipitated protein was then collected by centrifugation at 10 000 g for 30 min, dried and resuspended in simplified high salt buffer with urea (10 mM Tris-OAc (pH = 7.5 at 4°C), 10 mM Mg(OAc)2, 200 mM KGlu, 1 mM DTT, 6 M urea (buffer was mixed with 1 g/l bentonite for 1 h at 4°C and bentonite was filtered out (0.2 μm) prior to use)). The sample was transferred to midi-size 1000 Da MWCO Tube-O-Dialyzers (G-Biosciences) and dialyzed overnight against 100 volumes of simplified high salt buffer with urea. The sample was then dialyzed against 100 volumes of simplified high salt buffer without urea three times for 90 min each. This sample was clarified at 4000 g for 10 min and concentration was determined from A230 NanoDrop readings (1 A230 unit of TP70 = 240 pmol TP70 (29)). TP70 samples were then aliquoted, flash-frozen and stored at −80°C.
Total RNA of 70S ribosomes (TR70) preparation
Purified E. coli 70S ribosomes were diluted below 250 A260/ml with Buffer C and mixed with 0.1 volume 10% w/v SDS, 0.05 volume 2% w/v bentonite and 1.0 volume 70% v/v phenol. The sample was vortexed for 8 min at 4°C, then centrifuged at 12 500 g for 15 min. The aqueous phase was collected, mixed with 1.0 volume 70% v/v phenol, shaken for 5 min at 4°C, centrifuged at 12 500 g for 15 min and collected again. 2 volumes of chilled ethanol were added, and the sample was stored at −20°C overnight to precipitate rRNA. Precipitant was collected by centrifugation at 15 000 g for 45 min, washed with 0.5 volumes ethanol and dried. TR70 pellets were then resuspended in Buffer J (10 mM Tris-OAc (pH = 7.5 at 4°C) and 7.5 mM Mg(OAc)2) and concentration was determined from A260 NanoDrop readings (1 A260 unit of TR70 = 24 pmol TR70 (29)). TR70 samples were then aliquoted, flash-frozen and stored at −80°C.
T7 RNA polymerase preparation
T7 RNAP was prepared as previously described (30). Then, T7 RNAP was dialyzed in a midi-size 1000 Da MWCO Tube-O-Dialyzer overnight at 4°C, against 100 volumes of the same simplified high salt buffer without urea used for TP70 preparation (see above). T7 RNAP was then concentrated in 3000 Da MWCO Centriprep concentrators by spinning at 10 000 g for 15–45 min intervals. T7 RNAP was concentrated to 1.5 mg/ml, as determined by Bradford assay using BSA standards.
Plasmid constructions
Primers used for plasmid constructions are listed in Supplementary Table S1. 3′ modifications to rRNA-encoding plasmids pWK1 (16S rRNA) (31) or pCW1 (23S rRNA) (32) were introduced through inverse polymerase chain reaction (PCR) with phosphorylated primers and blunt end ligation of the linear product. Upon transformation and plasmid purification, the resulting constructs were DNA sequenced by the Northwestern University Genomics Core to confirm proper modifications. For constructs including ribozymes, the terminated constructs p16S-T and p23S-T were first created and the ribozyme sequences were inserted between the rRNA gene and terminator sequence using a similar method. Likewise, inverse PCR and blunt end ligation was used for insertion of the T7 promoter sequence into pAM552A, a derivative of the pLK35 plasmid encoding the rrnB operon (33), to create pT7rrnB. The A2058U clindamycin resistance mutation of 23S rRNA was introduced into the 23S rRNA gene sequence of pT7rrnB as previously reported (11).
iSAT and cell-free transcription and translation (TX-TL) reactions
Cell-free reactions were set up as previously described (11). Reagents are listed in Supplementary Table S2 showing concentration ranges used for optimizations. Reagents were premixed and added to S150 extract with purified ribosomal components (TP70, TR70 or 70S ribosomes) to a final volume of 15 μl. Tubes were then incubated at 37°C. The final optimized reaction conditions for the separate plasmid and operon-based iSAT systems are also shown in Supplementary Table S2.
iSAT ribosome purification
Twenty-four 15 μl operon-based iSAT reactions were incubated at 37°C for 3 h, placed on ice, pooled and diluted with 2 volumes of chilled Buffer A. Pooled iSAT reactions were then loaded into Ti70 ultracentrifuge tubes containing a 13 ml sucrose cushion of Buffer B with 10 ml of Buffer A layered on top. After loading the diluted iSAT reactions, tubes were filled to ∼26 ml with Buffer A, balanced, and spun at 90 000 g (35 000 rpm in Ti70 rotor) and 4°C for 18 h. Upon completion, supernatant was removed and the clear ribosome pellet was resuspended in a HEPES-based high salt buffer (50 mM HEPES-KOH (pH = 7.6 at room temperature), 10 mM MgGlu, 200 mM KGlu, 0.5 mM EDTA, 1 mM spermidine, 1 mM putrescine, 2 mM DTT). The concentration of purified iSAT ribosomes was determined from A260 NanoDrop readings (1 A260 unit of 70S = 24 pmol 70S (29)). To assess the activity of iSAT-assembled ribosomes, purified iSAT ribosomes were then used at reaction concentrations of 100 nM in S150 extract-based cell-free TX-TL reactions as described above.
Luciferase quantification
When producing luciferase as a reporter protein from the plasmid pK7Luc, 15 μl iSAT reactions were performed in 1.5 ml microtubes and incubated in heat blocks within an incubator for 4 h. Microtubes were then placed on ice to stop the reactions. Luciferase concentration in each reaction was determined by mixing 1–10 μl of sample with 30 μl ONE-GloTM Luciferase Assay System (Promega) in a white half-area 96-well plate. Resulting luminescence was read at 26°C in a BioTek Synergy2 plate reader over 20 min. The maximum relative luminescence units were converted to molar concentrations using a standard curve generated from a dilution series of QuantiLum® recombinant luciferase (Promega). To control for background expression, reactions were performed without additional rRNA or rRNA genes and assessed for active luciferase production, and this value (∼1 nmol/l at 4 h) was subtracted from experimental expression values.
sfGFP quantification
When producing superfolder GFP (sfGFP) as a reporter protein from the plasmid pY71sfGFP, 15 μl iSAT reactions were performed in flat-capped PCR tubes and incubated in a CFX96TM real-time thermal cycler (Bio-Rad). sfGFP production was monitored by measuring fluorescence at 5 or 30 min intervals (excitation: 450–490 nm, emission: 510–530 nm). Relative fluorescence units were converted to molar concentrations using a standard curve generated from a dilution series of purified recombinant sfGFP. As with luciferase, control reactions were performed without additional rRNA or rRNA genes and assessed for active sfGFP production, and this value (∼15 nmol/l at 6 h) was subtracted from experimental expression values.
RNA denaturing agarose gel electrophoresis
Agarose gels were prepared with 1.0% agarose, 2.2 M formaldehyde, 1× MOPS buffer (20 mM MOPS, 2 mM NaOAc, 1 mM EDTA, adjusted to pH 7.0 with NaOH) and 1× GelRedTM dye (Biotium). Samples were prepared by RNA purification of standard iSAT reactions without reporter plasmid using Bio-Rad's AurumTM Total RNA Mini kit. The kit's bacteria protocol was followed with the exception of initial lysozyme treatment, as no cell lysis was required. Controls included purified rRNA from subunits or ribosomes and prepared as previously reported (11). Ladder was 0.5–10 kb RNA ladder from Life Technologies. Samples, ladders and controls were denatured in 1× blue loading dye (New England BioLabs), 1× MOPS buffer, 40% formamide and 8% formaldehyde at 70°C for 10 min, and then placed on ice for 5 min. Gels were pre-run at 100 V for 10 min. Gels were then loaded with RNA and run at 50 V for 3 h. Upon completion, gels were imaged in a Bio-Rad Gel DocTM XR+ station. Images were inverted and contrast was adjusted to improve band visibility, and band intensities were approximated with Image Lab™ software.
RESULTS
Optimization of iSAT reaction conditions
As previously described, 70S iSAT reactions consist of transcription of 16S and 23S rRNA, assembly of rRNA with purified TP70, and measurement of ribosome activity by transcription and translation of a reporter gene, either luciferase or superfolder GFP (sfGFP) (Figure 1). These processes occur simultaneously at 37°C in 15 μl reactions. The reactions consist of crude ribosome-free S150 E. coli extract containing cytoplasmic translation and assembly factors, and salts, buffers and substrates necessary for transcription and translation (Supplementary Table S1) (11,12).
The goal of this study was to improve iSAT through transcriptional tuning of the rRNA. First, however, we hypothesized that increasing the concentration of the S150 extract components could improve iSAT activity. Previous iSAT work used dilute S150 cell extract (∼1 mg E. coli protein per milliliter reaction) (11), which is ∼200- to 300-fold less than typical E. coli cytoplasmic protein concentration (34). Since ribosome assembly and protein synthesis involves tens of enzymatic reactions, many of which are bimolecular, increasing the concentrations and hence proximity of enzymes and other mediating factors should increase the productivity of the system. Evidence supporting this idea was first established by concentrating S30 extract for CFPS reactions, leading to increased protein production rates and yields in both batch and continuous-exchange S30 extract-based CFPS systems (35,36). In iSAT reactions, the total extract protein concentration is roughly 10-fold lower than typical S30 extract-based systems, suggesting opportunity for improving activity by S150 extract concentration.
To assess the impact of S150 extract concentration, we measured the protein synthesis yield in iSAT reactions as a function of final extract protein concentration. The total S150 extract protein concentration was varied from 1.1 to 1.8 mg/ml and changes in volume were offset by addition of S150 extract buffer to maintain consistent salt concentrations. Over this range, iSAT reactions showed a strong upward trend in protein synthesis activity (Supplementary Figure S1), achieving a 5-fold improvement in luciferase production when comparing the highest and lowest extract protein concentrations. Further increases in extract protein concentration, however, were restricted by extract protein aggregation and the need for manipulation of other component volumes within the 15 μl reaction. As a control, we confirmed that the activity of our in vitro transcribed rRNA was not the result of unmasking some minor level of contaminating native rRNA from S150 extract or purified TP70; adding TP70 alone did not account for our observed protein synthesis (11). The increase of extract volume required re-optimization of salt and polyamine concentrations, resulting in an additional 50% improvement in iSAT protein synthesis activity (Supplementary Figure S2).
3′ modifications of rRNA gene constructs
A key limitation in the original iSAT system was the choice of plasmids encoding 16S and 23S rRNA (pWK1 and pCW1, respectively (31,32)). To produce 16S and 23S rRNA of the proper length, these plasmids need to be linearized prior to in vitro transcription (IVT) (31,32). However, our S150 extract contains endonucleases that degrade linear DNA templates, so pWK1 and pCW1 were used in iSAT as circular DNA with no defined 3′ transcriptional termination (11). Without termination, additional 3′ bases are expected on the rRNA, which may interfere with ribosome assembly and activity. Therefore, we introduced modifications at the 3′ end of rRNA genes to assess whether iSAT activity could be increased through improved rRNA processing and transcriptional efficiency.
We tried several strategies, including: (i) 3′ linearization of pWK1 and pCW1 by the restriction enzymes Bsu36I and AflII, respectively, (ii) termination with T7-TΦ terminators (37), (iii) addition of genes for the self-cleaving hepatitis delta virus (HDV) ribozyme (genomic variant) followed by a T7-TΦ terminator (38) or (iv) addition of genes for the self-cleaving hammerhead (HH) ribozyme (genomic variant from lucerne transient streak virus satellite RNA, satLTSV+) followed by a T7-TΦ terminator (39) (Figure 1). These modifications were introduced for both the 16S and 23S rRNA genes on separate plasmids and iSAT reactions were performed to assess impact on protein synthesis. iSAT reactions were assessed for synthesis of either luciferase after 4 h of incubation (Figure 2A) or sfGFP from 0 to 6 h of incubation (Figure 2B).
As previously observed, linearized plasmids are not viable in iSAT reactions (11). Other modifications, however, showed improvement over the original pWK1 and pCW1 constructs. Addition of T7-TΦ terminators to the 16S and 23S rRNA genes improved both luciferase and sfGFP production by 2.4-fold. Inclusion of 3′ HDV or HH ribozymes also resulted in increased protein production: for HDV, 1.5-fold for luciferase and 1.9-fold for sfGFP, and for HH, 4.8-fold for each reporter protein.
To assess the impact of 3′ modifications on rRNA processing, rRNA purified from iSAT reactions without reporter plasmids were run on a denaturing agarose gel (Figure 2C). Similar reactions were performed with 16S or 23S rRNA plasmids only in order to attribute over-transcribed (OT) RNA bands to 16S or 23S rRNA transcription (Supplementary Figure S3). While 16S and 23S rRNA are expected to run at 1.5 and 2.9 kb, respectively, the original plasmids pWK1 and pCW1 show several OT bands; bands near 2.8 and 7.5 kb are attributed to 16S rRNA over-transcription, and the band at 4.2 kb is attributed to 23S rRNA over-transcription (Figure 2C). Modifications to the plasmids dramatically altered the resulting rRNA. For linearized plasmids, no significant rRNA production beyond contaminating 16S rRNA from the extract was observed on the gel. Meanwhile, T7-TΦ terminated constructs showed a dramatic decrease in OT bands (Figure 2C). Upon addition of the terminators, all three OT bands decreased in intensity, with only the 2.8 kb band still visible. The persistence of the 2.8 kb band is consistent with estimates that the T7-TΦ terminator is 66% efficient (40). Inclusion of 3′ HDV or HH ribozymes eliminated the remaining portion of the 2.8 kb band (Figure 2C). In addition, a 1.3 kb band emerged that likely represents the cleavage product of the 2.8 kb OT band into the correct 16S rRNA size of 1.5 kb. These data suggest that the improved iSAT activity results from the production of rRNA molecules closer to the proper native length.
Concentration optimization of transcriptional components
An immediate observation from Figure 2C is that 16S and 23S rRNA are not stoichiometrically balanced. Based on band intensities and relative molecular weights, the HH constructs resulted in approximately 2.5 times more 16S rRNA than 23S rRNA on a molar basis. In comparison, native purified rRNA, TR70, showed equimolar quantities as expected (Figure 2C, Lane 1). Further complicating the issue of transcriptional stoichiometry is the need for T7 RNAP to also transcribe reporter protein mRNA. Therefore, we next asked whether iSAT activity could be improved through optimization of plasmid and RNAP concentrations.
Using the HH ribozyme constructs, iSAT reactions were performed with various concentrations of pK7Luc, p16S-HH and p23S-HH in a simplex lattice experimental design (Figure 3A). Based on the need for greater 23S rRNA transcription, p23S-HH concentration was varied from 0 to 10 nM, while pK7Luc and p16S-HH concentrations were only varied from 0 to 2 nM. From this experiment, the molar ratio of pK7Luc to p16S-HH to p23S-HH was set at 2:1:10. The need for excess p23S-HH agrees with the observation that insufficient amounts of 23S rRNA were being transcribed (Figure 2C). Based on these plasmid ratios, total plasmid and T7 RNAP concentrations were varied to determine optimal concentrations for iSAT protein synthesis activity (Figure 3B). Activity was highest for plasmids at a basis of 20 nM p23S-HH (with other plasmids at the set ratio) and 30 ng/μl T7 RNAP, though Figure 3B shows that inversely varying these concentrations also results in high activity.
We next asked whether TP70 concentration could be varied using the improved transcriptional conditions for RNAP and rRNA plasmid concentrations to increase iSAT activity (Figure 3C). While increasing TP70 concentration up to 100 nM increased protein synthesis activity, addition of TP70 beyond 100 nM resulted in visible turbidity and no further increase in protein synthesis (Figure 3C). As S150 and TP70 use similar storage buffers, this result suggests that protein aggregation occurs upon mixing the two protein solutions at high concentrations; it is not possible to assemble more than 100 nM ribosomal equivalents in this iSAT reaction.
Overall, transcriptional tuning of key iSAT components resulted in a 47% improvement in 70S iSAT protein synthesis activity (Figure 3D). However, visualization of the rRNA from an optimized iSAT reaction shows that 16S and 23S rRNA are still not expressed at stoichiometrically balanced levels, as the longer 23S rRNA band should be more intense than an equimolar amount of 16S rRNA (Figure 3E).
Use of T7-promoted native rRNA operon in iSAT reactions
To achieve stoichiometric balance of rRNA transcription, we looked to nature for inspiration. In vivo ribosome biogenesis utilizes co-transcription of operons encoding 5S, 16S and 23S rRNA. However, use of an operon in iSAT reactions would depend on the correct folding of intergenic regions into stem loops and the presence and activity of RNases required for processing of the operon into individual rRNA molecules (5,6) (Figure 4A). We asked whether a native rRNA operon could be transcribed and assembled into active ribosomes in the iSAT system, hypothesizing that enzymes in the crude S150 extract could process in vitro transcribed RNA of the operon. We placed the rrnB rRNA operon behind a T7 promoter and the resulting construct, pT7rrnB, was used in place of separate plasmids encoding 16S and 23S rRNA.
Despite previous reports that plasmid-borne rRNA from a T7-promoted rRNA operon at 37°C leads to hardly any assembled and active 70S ribosomes in vivo (10), our initial experiments showed that using a T7-promoted rRNA operon in the iSAT system resulted in functional ribosomes. Therefore, we carried out a series of optimization reactions to explore the effect of transcriptional component concentrations on the operon-based iSAT system. First, optimization of the plasmid ratio showed a 1:1 molar ratio of pK7Luc to pT7rrnB resulted in maximal activity (Figure 4B). Next, optimization of plasmid and T7 RNAP concentrations (Figure 4C) showed a trend similar to that seen for the separate plasmid system (Figure 3B); inversely varying T7 RNAP and plasmid concentrations resulted in the highest activities. Based on these data, for maximal protein synthesis, plasmid concentrations were set at 4 nM for each plasmid and 30 ng/μl for T7 RNAP. Finally, varying the TP70 concentration showed no significant increase in operon-based iSAT activity beyond 100 nM TP70 (Supplementary Figure S4), also similar to the separate plasmid iSAT system. Overall, the operon-based system showed a 39% increase in luciferase synthesis over the optimized separate plasmid system, and a total 45-fold improvement over the original iSAT conditions (Figure 4D).
Since iSAT reactions using the pT7rrnB operon plasmid resulted in active protein synthesis, we hypothesized that the RNA was correctly processed into individual rRNA molecules. To test this hypothesis, iSAT reactions were incubated without reporter plasmid for visualization of the transcribed rRNA. As a control for RNA self-cleavage, an IVT reaction using S150 extract buffer in place of S150 extract was performed to determine if extract proteins (e.g. RNA processing enzymes) were responsible for any observed RNA processing. Total RNA of each reaction was purified and run on a denaturing agarose gel (Figure 4E). RNA of the IVT reaction appears at approximately 5.5 kb, the size of the complete, unprocessed operon. In contrast, the operon-based iSAT reaction shows strong bands at the correct 16S and 23S rRNA sizes, though smearing larger than the 16S band may indicate incomplete processing of 16S rRNA precursors. Additionally, the ratio of 16S and 23S rRNA in the operon-based iSAT reaction closely matches the ratio of the control rRNA bands; quantification of band intensity shows that the operon-based iSAT system generates approximately equimolar amounts of 16S and 23S rRNA.
Since the ability to manipulate rRNA sequence, particularly that of the 23S rRNA, is a key feature of the iSAT system, we wished to demonstrate the incorporation of unique functionality into ribosomes generated from the operon. As previously reported, iSAT technology utilizing the separate plasmid system can be used to generate ribosomes that are resistant to the antibiotic clindamycin via a 23S rRNA point mutation, A2058U (11). The same approach was applied here by introducing the A2058U mutation into the 23S rRNA gene of pT7rrnB. The construct conferring clindamycin resistance, pT7rrnB-CR, was used in iSAT reactions with and without clindamycin. At 50 ng/μl clindamycin, ribosomes derived from transcription of pT7rrnB-CR retained 51% activity, whereas ribosomes derived from transcription of pT7rrnB retained 0.5% activity, as defined by batch luciferase synthesis yields (Figure 5). This result demonstrates the potential for constructing mutant ribosomes directly from rRNA operon plasmid DNA in a one-step reaction, streamlining the process for in vitro ribosome construction and study.
Comparison of 70S iSAT ribosomes to assembled or purified 70S ribosomes
Activity of ribosomes created in iSAT reactions depends on both transcriptional and assembly processes, as well as protein synthesis. To separate the current limitations associated with each process, protein synthesis activities were compared for operon-based iSAT 70S ribosomes, 70S ribosomes assembled in S150 extract from purified rRNA and purified r-proteins (‘assembled 70S’) and purified, intact 70S ribosomes (Figure 6A). To maintain equivalent transcriptional load on the T7 RNAP, pT7rrnB was included in all reactions, as pilot studies showed no effect of excess transcribed rRNA on assembled or purified ribosome activity (data not shown). Protein synthesis by iSAT ribosomes relative to assembled ribosomes was 83% and 105% for luciferase and sfGFP, respectively (Figure 6B and C). On the other hand, purified 70S ribosomes resulted in greater luciferase and sfGFP synthesis than iSAT ribosomes (Figure 6B and C). However, it was difficult to directly compare these reactions because reactions with purified 70S ribosomes do not have a lag time associated with rRNA synthesis and ribosome assembly. In addition, while iSAT ribosome assembly was capped at 100 nM by the TP70 concentration, the true concentrations of iSAT ribosomes in the reactions were unknown. Therefore, we purified iSAT-assembled 70S ribosomes directly from iSAT reactions through ultracentrifugation on a sucrose cushion, resuspension in a HEPES-based high salt buffer, and quantification from A260 readings (Figure 7A). Purified iSAT ribosomes were subsequently added to a cell-free transcription and translation reaction for synthesis of sfGFP. This allowed for the direct comparison of the translational activity of 100 nM each of iSAT 70S ribosomes versus purified E. coli 70S ribosomes (Figure 7B). After a 6 h batch reaction at 37°C, we observed that iSAT-assembled ribosomes have about 20% the activity of purified native ribosomes.
DISCUSSION
iSAT provides a powerful new tool for observation and study of ribosome biogenesis under more physiological conditions than conventional reconstitution (11). Specifically, the system enables rRNA transcription to be integrated with ribosome assembly and protein synthesis. Here, we demonstrated that transcriptional tuning is critical for iSAT, with advances producing a 45-fold increase in 70S iSAT activity relative to previous results (11). Importantly, iSAT ribosomes now display ∼85–100% protein synthesis activity compared to ribosomes assembled from purified native rRNA. This contrasts with conventional E. coli ribosome reconstitution protocols, whereby 50S subunits assembled from in vitro transcripts of E. coli 23S rRNA have ∼0.02–3% the activity of those assembled from mature rRNA (8,25). Thus, the iSAT platform provides significant efficiency advantages as compared to previous works, noting that the measure of functional activity in iSAT reactions is the synthesis of full-length, easy to monitor reporter proteins.
Transcriptional tuning of iSAT reactions resulted in improvements to protein synthesis activity and enhanced our understanding of the system. First, we demonstrated that a synthetic approach, the introduction of ribozyme sequences to the 3′ end of rRNA gene constructs, improved iSAT activity 5-fold by processing rRNA and reducing the presence of over-transcribed RNA bands. However, our data indicated that we were not producing stoichiometric amounts of rRNA as occurs for in vivo ribosome biogenesis. Thus, we further improved iSAT activity by adjusting plasmid and RNAP concentrations. Because the plasmid concentrations were interdependent, we applied a simplex lattice experimental design, observing that the optimal ratio of 23S to 16S rRNA plasmid was 10:1. These data implied that the assembly of 50S subunits limited the construction of 70S ribosomes in iSAT.
Modification of rRNA-encoding plasmids and optimization of component concentrations improved iSAT activity, and further highlighted the need to better mimic rRNA synthesis as it occurs in vivo. We therefore turned to the native rRNA operon to further improve in vitro ribosome construction through stoichiometric expression of rRNA molecules and utilization of native rRNA processing mechanisms. RNA gel analysis of operon-based iSAT reactions clearly shows more efficient and stoichiometrically balanced rRNA transcription than the previous iSAT system. We observed more efficient 23S rRNA synthesis and processing from less plasmid when using the T7-promoted rrnB operon, suggesting that strong determinants for ordered assembly are found in the various operon sequence components. That said, the presence of longer 16S rRNA precursors suggests incomplete processing by RNases in the S150 extract, hinting that effective processing of all rRNA may further improve iSAT activity. One cause of incomplete processing may be the use of an RNase inhibitor cocktail in the preparation of S150 extract, which may affect the activity of RNases required for operon processing (5,6). Alternatively, the use of T7 polymerase may cause transcription to occur too quickly for correct folding or processing of all rRNA molecules.
We were surprised that the T7-promoted rRNA operon construct worked so well in vitro at 37°C. This result could imply that the rRNA transcription rate by T7 RNAP and the corresponding ribosome assembly rate are more similar in the iSAT system than what occurs in vivo, which allows for in vitro construction of functional 70S ribosomes at 37°C. As a follow-on experiment, we prepared iSAT reactions using an rrnB operon behind the strong leftward promoter (PL) of bacteriophage lambda; the PL-promoter constitutively utilizes native E. coli RNAP (41). We showed that this construct also resulted in iSAT protein synthesis activity, even without addition of E. coli RNAP (Supplementary Figure S5). Importantly, this suggests that the native RNAPs are present and active in S150 extract. These experiments further support the ability of S150 extract proteins to facilitate in vitro ribosome construction. Additionally, we demonstrated that the operon-based iSAT system was susceptible to rRNA sequence modification by creating clindamycin-resistant ribosomes through a point mutation of the operon, as previously shown for the separate plasmid iSAT system (11).
Figure 7 shows that the overall protein synthesis activity of iSAT ribosomes is now about 20% that of purified 70S ribosomes. Even though this opens the way to using iSAT for studying ribosome synthesis, there are still some exciting opportunities to further improve the efficiency of iSAT and characterize generated ribosomes. First, differences in iSAT-assembled ribosomes and purified E. coli ribosomes may impact activity. Thus, there is a need to characterize the molecular and functional components of iSAT ribosomes. We are interested to know, for example, if the rRNA is being post-transcriptionally modified in the lysate. The status of the rRNA modifications is currently unknown, and a focal point of future work. A new method for analyzing rRNA modifications by isotope labeling and mass spectrometry was recently published by Popova and Williamson (42), and such a method coupled with the iSAT technology could provide new insight into ribosome biogenesis. Second, we hypothesize that substrate instabilities, typically present in cell-free transcription and translation systems (13), could limit iSAT reactions. In subsequent work, we are exploring the causes of reaction termination in iSAT to improve activity and protein yields. Third, TP70 and S150 protein stability and concentration impact assembly efficiency (Figure 3C, Supplementary Figures S1 and S4). TP70 concentration caps iSAT ribosome concentration at 100 nM, while in vivo ribosome concentrations range from approximately 10 to 100 μM (43). Additionally, S150 extract protein concentration, now at 1.8 mg/ml, is still significantly more dilute than E. coli cytoplasmic conditions (34). Achieving protein concentrations in iSAT reactions closer to in vivo concentrations will be a critical next step toward fully replicating ribosome biogenesis in vitro. Even though there are opportunities to improve iSAT technology, the 45-fold improvement in iSAT protein synthesis presented in this work is a significant advancement that increases the potential applications of this technology.
In summary, the advances to iSAT reported here will enable future studies to tease apart functions of individual ribosomal components and steps in ribosome biogenesis processes, and ultimately in the ability to make modified ribosomal variants with new functionalities. In vivo ribosome studies are limited by cell viability constraints and transformation efficiencies (7). The iSAT technology should overcome these restrictions, allowing for in-depth understanding and manipulation of complex 70S ribosomes. For example, the demonstration of rRNA processing in iSAT suggests that this approach can be used to explore the systems-level impact of positive and negative effectors of ribosome biogenesis. Currently, over 20 E. coli proteins have been identified as ribosomal assembly cofactors, including helicases, GTPases and chaperones, which facilitate RNA folding and RNA–protein interactions in the formation of the 30S and 50S subunits (6,44). iSAT can provide an alternative approach to assess the impact of these factors on wild-type and mutant ribosomes by modulating the extract source strain (e.g. deletion mutants, etc.). Looking forward, we anticipate that iSAT will contribute meaningfully towards efforts to completely synthesize ribosomes in vitro and provide new opportunities to engineering ribosomes with altered properties.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Acknowledgments
We are grateful to Laura Timmerman and Dr Anne Bunner for discussions and research leading to improvements in the iSAT system; Adam Hockenberry for thoughtful review of the manuscript; Erik Carlson for providing the HDV and HH ribozyme constructs and for thoughtful review of the manuscript; Dr Olke Uhlenbeck and Dr Margaret Saks for scientific discussions; Dr Jim Swartz for providing the pY71sfGFP reporter plasmid; and Dr Alexander Mankin for providing the pAM552A plasmid encoding the rrnB operon.
Author contributions: M.C.J. and B.R.F. conceived the study and wrote the manuscript. B.R.F. designed and performed experiments. M.C.J. provided a supervisory role.
FUNDING
Office of Naval Research [N00014-11-1-0363]; National Institutes of Health [GM081450]; National Science Foundation [MCB 0943383]; Northwestern University Biotechnology Training Program (B.R.F., in part). M.C.J. is a Packard Fellow for Science and Engineering. Source of open access funding: Office of Naval Research [N00014-11-1-0363].
Conflict of interest statement. None declared.
REFERENCES
- 1.Mulder A.M., Yoshioka C., Beck A.H., Bunner A.E., Milligan R.A., Potter C.S., Carragher B., Williamson J.R. Visualizing ribosome biogenesis: parallel assembly pathways for the 30S subunit. Science. 2010;330:673–677. doi: 10.1126/science.1193220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Pulk A., Liiv A., Peil L., Maivali U., Nierhaus K., Remme J. Ribosome reactivation by replacement of damaged proteins. Mol. Microbiol. 2010;75:801–814. doi: 10.1111/j.1365-2958.2009.07002.x. [DOI] [PubMed] [Google Scholar]
- 3.Talkington M.W., Siuzdak G., Williamson J.R. An assembly landscape for the 30S ribosomal subunit. Nature. 2005;438:628–632. doi: 10.1038/nature04261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ridgeway W.K., Millar D.P., Williamson J.R. Quantitation of ten 30S ribosomal assembly intermediates using fluorescence triple correlation spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 2012;109:13614–13619. doi: 10.1073/pnas.1204620109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kaczanowska M., Ryden-Aulin M. Ribosome biogenesis and the translation process in Escherichia coli. Microbiol. Mol. Biol. Rev. 2007;71:477–494. doi: 10.1128/MMBR.00013-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Shajani Z., Sykes M.T., Williamson J.R. Assembly of bacterial ribosomes. Annu. Rev. Biochem. 2011;80:501–526. doi: 10.1146/annurev-biochem-062608-160432. [DOI] [PubMed] [Google Scholar]
- 7.Cochella L., Green R. Isolation of antibiotic resistance mutations in the rRNA by using an in vitro selection system. Proc. Natl. Acad. Sci. U.S.A. 2004;101:3786–3791. doi: 10.1073/pnas.0307596101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Green R., Noller H.F. In vitro complementation analysis localizes 23S rRNA posttranscriptional modifications that are required for Escherichia coli 50S ribosomal subunit assembly and function. RNA. 1996;2:1011–1021. [PMC free article] [PubMed] [Google Scholar]
- 9.Alix J.H., Hayes D., Nierhaus K.H. Properties of ribosomes and RNA synthesized by Escherichia coli grown in the presence of ethionine. V. Methylation dependence on the assembly of E. coli 50 S ribosomal subunits. J. Mol. Biol. 1979;127:375–395. doi: 10.1016/0022-2836(79)90228-6. [DOI] [PubMed] [Google Scholar]
- 10.Lewicki B.T., Margus T., Remme J., Nierhaus K.H. Coupling of rRNA transcription and ribosomal assembly in vivo. Formation of active ribosomal subunits in Escherichia coli requires transcription of rRNA genes by host RNA polymerase which cannot be replaced by bacteriophage T7 RNA polymerase. J. Mol. Biol. 1993;231:581–593. doi: 10.1006/jmbi.1993.1311. [DOI] [PubMed] [Google Scholar]
- 11.Jewett M.C., Fritz B.R., Timmerman L.E., Church G.M. In vitro integration of ribosomal RNA synthesis, ribosome assembly, and translation. Mol. Syst. Biol. 2013;9:678. doi: 10.1038/msb.2013.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Jewett M.C., Swartz J.R. Mimicking the Escherichia coli cytoplasmic environment activates long-lived and efficient cell-free protein synthesis. Biotechnol. Bioeng. 2004;86:19–26. doi: 10.1002/bit.20026. [DOI] [PubMed] [Google Scholar]
- 13.Carlson E.D., Gan R., Hodgman C.E., Jewett M.C. Cell-free protein synthesis: applications come of age. Biotechnol. Adv. 2012;30:1185–1194. doi: 10.1016/j.biotechadv.2011.09.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Forster A.C., Church G.M. Towards synthesis of a minimal cell. Mol. Syst. Biol. 2006;2:45. doi: 10.1038/msb4100090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Jewett M.C., Forster A.C. Update on designing and building minimal cells. Curr. Opin. Biotechnol. 2010;21:697–703. doi: 10.1016/j.copbio.2010.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Glass J.I., Assad-Garcia N., Alperovich N., Yooseph S., Lewis M.R., Maruf M., Hutchison C.A., Smith H.O., Venter J.C. Essential genes of a minimal bacterium. Proc. Natl. Acad. Sci. U.S.A. 2006;103:425–430. doi: 10.1073/pnas.0510013103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Juhas M., Eberl L., Glass J.I. Essence of life: essential genes of minimal genomes. Trends Cell Biol. 2011;21:562–568. doi: 10.1016/j.tcb.2011.07.005. [DOI] [PubMed] [Google Scholar]
- 18.Stano P., Luisi P.L. Semi-synthetic minimal cells: origin and recent developments. Curr. Opin. Biotechnol. 2013;24:633–638. doi: 10.1016/j.copbio.2013.01.002. [DOI] [PubMed] [Google Scholar]
- 19.Maki J.A., Schnobrich D.J., Culver G.M. The DnaK chaperone system facilitates 30S ribosomal subunit assembly. Mol. Cell. 2002;10:129–138. doi: 10.1016/s1097-2765(02)00562-2. [DOI] [PubMed] [Google Scholar]
- 20.Calidas D., Culver G.M. Interdependencies govern multidomain architecture in ribosomal small subunit assembly. RNA. 2011;17:263–277. doi: 10.1261/rna.2332511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Erlacher M.D., Chirkova A., Voegele P., Polacek N. Generation of chemically engineered ribosomes for atomic mutagenesis studies on protein biosynthesis. Nat. Protoc. 2011;6:580–592. doi: 10.1038/nprot.2011.306. [DOI] [PubMed] [Google Scholar]
- 22.Nierhaus K.H., Dohme F. Total reconstitution of functionally active 50S ribosomal subunits from Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 1974;71:4713–4717. doi: 10.1073/pnas.71.12.4713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Traub P., Nomura M. Structure and function of E. coli ribosomes. V. Reconstitution of functionally active 30S ribosomal particles from RNA and proteins. Proc. Natl. Acad. Sci. U.S.A. 1968;59:777–784. doi: 10.1073/pnas.59.3.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Khaitovich P., Tenson T., Kloss P., Mankin A.S. Reconstitution of functionally active Thermus aquaticus large ribosomal subunits with in vitro-transcribed rRNA. Biochemistry. 1999;38:1780–1788. doi: 10.1021/bi9822473. [DOI] [PubMed] [Google Scholar]
- 25.Semrad K., Green R. Osmolytes stimulate the reconstitution of functional 50S ribosomes from in vitro transcripts of Escherichia coli 23S rRNA. RNA. 2002;8:401–411. doi: 10.1017/s1355838202029722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Hui A., de Boer H.A. Specialized ribosome system: preferential translation of a single mRNA species by a subpopulation of mutated ribosomes in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 1987;84:4762–4766. doi: 10.1073/pnas.84.14.4762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Barrett O.P., Chin J.W. Evolved orthogonal ribosome purification for in vitro characterization. Nucleic Acids Res. 2010;38:2682–2691. doi: 10.1093/nar/gkq120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Jewett M.C., Calhoun K.A., Voloshin A., Wuu J.J., Swartz J.R. An integrated cell-free metabolic platform for protein production and synthetic biology. Mol. Syst. Biol. 2008;4:220. doi: 10.1038/msb.2008.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Nierhaus K.H. Reconstitution of ribosomes. In: Spedding G, editor. Ribosomes and Protein Synthesis: A Practical Approach. Oxford: IRL Press; 1990. pp. 161–189. [Google Scholar]
- 30.Swartz J.R., Jewett M.C., Woodrow K.A. Cell-free protein synthesis with prokaryotic combined transcription-translation. Methods Mol. Biol. 2004;267:169–182. doi: 10.1385/1-59259-774-2:169. [DOI] [PubMed] [Google Scholar]
- 31.Krzyzosiak W.J., Denman R., Cunningham P.R., Ofengand J. An efficiently mutagenizable recombinant plasmid for in vitro transcription of the Escherichia coli 16S RNA gene. Anal. Biochem. 1988;175:373–385. doi: 10.1016/0003-2697(88)90560-x. [DOI] [PubMed] [Google Scholar]
- 32.Weitzmann C.J., Cunningham P.R., Ofengand J. Cloning, in vitro transcription, and biological activity of Escherichia coli 23S ribosomal RNA. Nucleic Acids Res. 1990;18:3515–3520. doi: 10.1093/nar/18.12.3515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Douthwaite S., Powers T., Lee J.Y., Noller H.F. Defining the structural requirements for a helix in 23 S ribosomal RNA that confers erythromycin resistance. J. Mol. Biol. 1989;209:655–665. doi: 10.1016/0022-2836(89)93000-3. [DOI] [PubMed] [Google Scholar]
- 34.Cayley S., Lewis B.A., Guttman H.J., Record M.T., Jr Characterization of the cytoplasm of Escherichia coli K-12 as a function of external osmolarity. Implications for protein-DNA interactions in vivo. J. Mol. Biol. 1991;222:281–300. doi: 10.1016/0022-2836(91)90212-o. [DOI] [PubMed] [Google Scholar]
- 35.Kigawa T., Yabuki T., Yoshida Y., Tsutsui M., Ito Y., Shibata T., Yokoyama S. Cell-free production and stable-isotope labeling of milligram quantities of proteins. FEBS Lett. 1999;442:15–19. doi: 10.1016/s0014-5793(98)01620-2. [DOI] [PubMed] [Google Scholar]
- 36.Kim D.M., Kigawa T., Choi C.Y., Yokoyama S. A highly efficient cell-free protein synthesis system from Escherichia coli. Eur. J. Biochem. 1996;239:881–886. doi: 10.1111/j.1432-1033.1996.0881u.x. [DOI] [PubMed] [Google Scholar]
- 37.Dunn J.J., Studier F.W. Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements. J. Mol. Biol. 1983;166:477–535. doi: 10.1016/s0022-2836(83)80282-4. [DOI] [PubMed] [Google Scholar]
- 38.Been M.D., Wickham G.S. Self-cleaving ribozymes of hepatitis delta virus RNA. Eur. J. Biochem. 1997;247:741–753. doi: 10.1111/j.1432-1033.1997.00741.x. [DOI] [PubMed] [Google Scholar]
- 39.Shepotinovskaya I.V., Uhlenbeck O.C. Catalytic diversity of extended hammerhead ribozymes. Biochemistry. 2008;47:7034–7042. doi: 10.1021/bi7025358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Macdonald L.E., Zhou Y., McAllister W.T. Termination and slippage by bacteriophage T7 RNA polymerase. J. Mol. Biol. 1993;232:1030–1047. doi: 10.1006/jmbi.1993.1458. [DOI] [PubMed] [Google Scholar]
- 41.Horn G.T., Wells R.D. The leftward promoter of bacteriophage lambda. Structure, biological activity, and influence by adjacent regions. J. Biol. Chem. 1981;256:2003–2009. [PubMed] [Google Scholar]
- 42.Popova A.M., Williamson J.R. Quantitative analysis of rRNA modifications using stable isotope labeling and mass spectrometry. J. Am. Chem. Soc. 2014;136:2058–2069. doi: 10.1021/ja412084b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Bremer H., Dennis P.P. Modulation of chemical composition and other parameters of the cell by growth rate. In: Neidhardt FC, Curtiss R III, Ingraham JL, Lin ECC, Low KB, Magasanik B, Reznikoff WS, Riley M, editors. Escherichia coli and Salmonella: Cellular and Molecular Biology. 2nd edn. Washington, DC: American Society for Microbiology; 1996. pp. 1553–1569. [Google Scholar]
- 44.Wilson D.N., Nierhaus K.H. The weird and wonderful world of bacterial ribosome regulation. Crit. Rev. Biochem. Mol. Biol. 2007;42:187–219. doi: 10.1080/10409230701360843. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.